1. Home
  2. CRL vs NIO Comparison

CRL vs NIO Comparison

Compare CRL & NIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Charles River Laboratories International Inc.

CRL

Charles River Laboratories International Inc.

N/A

Current Price

$287.00

Market Cap

13.1B

Sector

Health Care

ML Signal

N/A

Logo NIO Inc. American depositary shares each  representing one ordinary share

NIO

NIO Inc. American depositary shares each representing one ordinary share

N/A

Current Price

$3.42

Market Cap

12.7B

ML Signal

N/A

Company Overview

Basic Information
Metric
CRL
NIO
Founded
1947
2014
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Commercial Physical & Biological Resarch
Auto Manufacturing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
13.1B
12.7B
IPO Year
1999
2018

Fundamental Metrics

Financial Performance
Metric
CRL
NIO
Price
$287.00
$3.42
Analyst Decision
Buy
Buy
Analyst Count
17
24
Target Price
★ $298.79
$6.30
AVG Volume (30 Days)
769.7K
★ 28.1M
Earning Date
11-04-2026
09-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $1,857,601,000.00
N/A
Revenue This Year
N/A
$46.59
Revenue Next Year
$2.24
$19.07
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 10.48
N/A
52 Week Low
$146.20
$3.38
52 Week High
$303.31
$7.86

Technical Indicators

Market Signals
Indicator
CRL
NIO
Relative Strength Index (RSI) 59.62 26.74
Support Level $267.27 N/A
Resistance Level $303.31 $3.79
Average True Range (ATR) 9.76 0.08
MACD 0.78 0.01
Stochastic Oscillator 83.37 10.98

Price Performance

Historical Comparison
CRL
NIO

About CRL Charles River Laboratories International Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provide in vitro (nonanimal) testing products, biologics testing services, and avian vaccine services.

About NIO NIO Inc. American depositary shares each representing one ordinary share

Nio is a leading electric vehicle maker, targeting the premium segment. Founded in November 2014, Nio designs, develops, jointly manufactures, and sells premium smart electric vehicles. The company differentiates itself through continuous technological breakthroughs and innovations, such as battery swapping and autonomous driving. Nio launched its first model, its ES8 seven-seater electric SUV, in December 2017, and began deliveries in June 2018. Its current model portfolio includes midsize to large sedans and SUVs. It sold around 326,000 EVs in 2025, accounting for about 2% of China's passenger new energy vehicle market.

Share on Social Networks: